White label ELPA - ClinicalTrials.eu

Long-term safety study of apraglutide (weekly injections) in patients with Short Bowel Syndrome

Not recruiting

3 1 1
Investigated diseases:
- Short-bowel syndrome
Investigated drugs:
- Apraglutide
+5
Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

Not recruiting

3 1 1 1
Investigated diseases:
- Multiple sclerosis
Investigated drugs:
- Ocrelizumab
+14
Study of CLR 131 for Patients with Relapsed or Refractory Waldenstrom Macroglobulinemia

Not recruiting

2 1 1 1
Investigated diseases:
- Waldenstrom’s macroglobulinaemia
Investigated drugs:
Study on the Safety and Effectiveness of AUTO1 for Adults with Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia Using a Drug Combination

Not recruiting

1 1 1 1
Investigated diseases:
- Acute lymphocytic leukaemia
Investigated drugs:
Study on Ofatumumab for Patients with Relapsing Multiple Sclerosis Transitioning from Fumarate-Based Therapies or Fingolimod

Not recruiting

3 1 1 1
Investigated diseases:
- Multiple sclerosis relapse
Investigated drugs:
- Ofatumumab
+2
Study of AMG 193 and IDE397 for Adults with Advanced MTAP-null Solid Tumors and Non-Small Cell Lung Cancer

Not recruiting

1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Ide397
- Amg 193
Study on the Safety and Efficacy of Linsitinib for Patients with Active, Moderate to Severe Thyroid Eye Disease

Not recruiting

2 1
Investigated diseases:
- Endocrine ophthalmopathy
Investigated drugs:
- Linsitinib
Study on the Effectiveness and Safety of Iptacopan for Patients with Complement 3 Glomerulopathy

Not recruiting

3 1
Investigated diseases:
- C3 glomerulopathy
Investigated drugs:
- Iptacopan Hydrochloride
- Iptacopan
+1
Study on the Effectiveness and Safety of Batoclimab for Adults with Generalized Myasthenia Gravis

Not recruiting

3 1
Investigated diseases:
- Myasthenia gravis
Investigated drugs:
- Batoclimab
Study on the Safety and Effectiveness of Sunvozertinib for Patients with Advanced Non-Small Cell Lung Cancer with EGFR or HER2 Mutations

Not recruiting

1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Sunvozertinib

powered by

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes